首页> 美国卫生研究院文献>Child Neurology Open >Clinical Phenotype of De Novo GNAO1 Mutation
【2h】

Clinical Phenotype of De Novo GNAO1 Mutation

机译:De Novo GNAO1突变的临床表型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in the guanine nucleotide-binding protein (G protein), α activating activity polypeptide O (GNAO1) gene have recently been described in 6 patients with early infantile epileptic encephalopathies. In the present study, we report the phenotype and the clinical course of a 4-year-old female with an epileptic encephalopathy (Ohtahara syndrome) and profound intellectual disability due to a de novo GNAO1 mutation (c.692A>G; p.Tyr231Cys). Ohtahara syndrome is a devastating early infantile epileptic encephalopathy that can be caused by mutations in different genes, now also including GNAO1. The mutation was found using a targeted next generation sequencing gene panel and demonstrates targeted sequencing as a powerful tool for identifying mutations in genes where only a few de novo mutations have been identified.
机译:最近有6例婴儿早期癫痫性脑病患者描述了鸟嘌呤核苷酸结合蛋白(G蛋白),α激活活性多肽O(GNAO1)基因的突变。在本研究中,我们报告了一名4岁女性,患有癫痫性脑病(Ohtahara综合征)且由于从头GNAO1突变(c.692A> G; p.Tyr231Cys)而导致严重智力残疾,其表型和临床病程)。 Ohtahara综合征是一种破坏性的早期婴儿癫痫性脑病,可能由不同基因的突变引起,现在也包括GNAO1。该突变是使用靶向的下一代测序基因组发现的,并证明了靶向测序是一种用于鉴定仅从头突变的基因的强大工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号